Back to all papers

COCOH: A Multimodal Deep Learning Framework for Cancer Risk Assessment of Oral Potentially Malignant Disorders

January 5, 2026medrxiv logopreprint

Authors

Adeoye, J.,Su, Y.-X.

Affiliations (1)

  • University of Hong Kong

Abstract

Oral potentially malignant disorders (OPMD) are mucosal diseases with an increased risk of progression to cancer, although not all cases develop cancer in patients lifetimes. Although epithelial dysplasia (ED) grading is the current approach for assessing the risk of malignant transformation (MT), cancer risk prediction is limited by its subjective interpretation and inaccuracy. To address these challenges, this study developed COCOH (Comprehensive Oral Cancer predictor in OPMD using Histopathology and immunohistochemistry), a multimodal attention-based deep multiple instance learning (MIL) framework that integrates disease information, hematoxylin and eosin (H&E), and Keratin-13 (KRT13) immunohistochemistry whole-slide images (WSIs) to predict MT risk in OPMD. Trained on 2,780 WSIs and over 2.7 million image patches from cases with oral leukoplakia and oral lichenoid disorders, COCOH achieved an AUC of 0.904 (0.843-0.965) and Brier score of 0.089 (0.044-0.134) during testing, with excellent discrimination and calibration maintained at prospective validation (AUC: 0.951 [0.897-1], Brier score: 0.062 [0.002-0.122]). Notably, the deep learning model outperformed two ED grading systems in assessing cancer risk in oral leukoplakia, yielding a significant net reclassification improvement of 20.2%. Decision curve analysis confirmed COCOHs clinical utility in identifying high-risk OPMD cases for intervention and close monitoring. These findings demonstrate that COCOH provides accurate and well-calibrated risk predictions for MT in OPMD, and its integration into clinical workflows could enhance prevention strategies and promote earlier detection of oral cancer.

Topics

oncology

Ready to Sharpen Your Edge?

Subscribe to join 8,100+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.